Smile Group has launched a Healthtech Venture Builder to tap into the rapidly growing healthcare sector, appointing industry veteran Gagandeep Singh Bedi as Managing Partner. With over 25 years of experience in pharma and healthcare, Bedi has held leadership roles at companies like AstraZeneca and Eli Lilly and has driven major growth and innovation initiatives.
The move aligns with Smile Group’s strategy of combining capital and operational expertise to build impactful ventures and support global healthtech players entering Asia. The healthtech market, particularly AI in healthcare, is projected to exceed $50 billion in APAC, with India’s market growing at 42% annually.
Smile Group founder Harish Bahl emphasized the sector’s potential and Bedi’s ideal fit for the role, given his blend of corporate leadership and startup ecosystem involvement.